
|Articles|January 21, 2022
In case you missed it: Jan. 17 to Jan. 21
Author(s)Lindsey Carr, Editor
Here's what you missed this week from Contemporary OB/GYN®.
Advertisement
The need for a universal endometriosis classification
A literature search revealed there is no international agreement on how to characterize or classify endometriosis.
Laparoscopic myomectomy vs. open myomectomy for treating uterine fibroids
The authors noted that both primary options for treatment are currently being debated as to their efficacy and safety.
Autophagy may contribute to endometriosis and uterine fibroids
Autophagy is a controlled lysosomal degradation pathway that protects cells and allows to overcome cell death.
Breastfeeding reduces women’s risk of CVD
These mothers are approximately 17% less likely to die from cardiovascular disease, 14% less likely to develop coronary heart disease, and 12% less likely to suffer a stroke, the data show.
Mild to moderate COVID-19 may have no effect on brain of developing fetuses
Study results show that fetal cognitive development in the assessed areas was age-appropriate and there was no indication of infection.
Advertisement
Related to this article

Susan Reed, MD, on the need for menopause research funding, a clinical trials network, and studies in understudied groups and perimenopause.

Chrisandra Shufelt, MD, on why menopause is a window for cardiovascular prevention and the risk factors OB/GYNs should assess.

Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.

ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.

Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.

Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.

In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG advises against GLP-1 receptor agonists during pregnancy
2
Safety Monitoring and Dosing for NK3 Antagonists in Menopause VMS
3
Matthew Nudy, MD, on estrogen and the cardiovascular system
4
Chrisandra Shufelt, MD, on cardiovascular prevention at menopause
5

